Overview

Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis

Status:
Completed
Trial end date:
2020-11-30
Target enrollment:
0
Participant gender:
All
Summary
The randomized control trial study aimed to evaluate effectiveness and safety of amphotericin B in 30% DMSO solution comparing with 30% DMSO solution in NDMs onychomycosis treatment.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mahidol University
Treatments:
Amphotericin B
Dimethyl Sulfoxide
Liposomal amphotericin B
Criteria
Inclusion Criteria:

1. Patients with non-dermatophyte onychomycosis.

2. Patients aged more than 18 years.

3. Patients has not been treated with any oral/ IV/ topical antifungal therapy within 36
weeks before enrolled.

Exclusion Criteria:

1. Patients had concomitant nail diseases.

2. Immunocompromised host.

3. Patients with dermatophyte onychomycosis.